. "Graft-versus-host disease (GvHD) is a syndrome, characterized by inflammation in different organs. GvHD is commonly associated with bone marrow transplants and stem cell transplants. White blood cells of the donor's immune system which remain within the donated tissue (the graft) recognize the recipient (the host) as foreign (non-self). The white blood cells present within the transplanted tissue then attack the recipient's body's cells, which leads to GvHD. This should not be confused with a transplant rejection, which occurs when the immune system of the transplant recipient rejects the transplanted tissue; GvHD occurs when the donor's immune system's white blood cells reject the recipient. The underlying principle (alloimmunity) is the same, but the details and course may differ. GvHD c"@en . . . . . . . . ""@en . . "Doen\u00E7a do enxerto contra hospedeiro"@pt . "\u79FB\u690D\u7247\u5BFE\u5BBF\u4E3B\u75C5\uFF08\u3044\u3057\u3087\u304F\u3078\u3093\u305F\u3044\u3057\u3085\u304F\u3057\u3085\u3073\u3087\u3046\u3001graft versus host disease; GVHD\uFF09\u3068\u306F\u81D3\u5668\u79FB\u690D\u306B\u4F34\u3046\u5408\u4F75\u75C7\u306E\u3072\u3068\u3064\u3002 \u79FB\u690D\u7247\uFF08\u30B0\u30E9\u30D5\u30C8\uFF09\u306B\u3068\u3063\u3066\u3001\u30EC\u30B7\u30D4\u30A8\u30F3\u30C8\uFF08\u81D3\u5668\u53D7\u7D66\u8005\uFF09\u306E\u4F53\u306F\u7570\u7269\u3067\u3042\u308B\u3002GVHD\u3068\u306F\u30C9\u30CA\u30FC\uFF08\u81D3\u5668\u63D0\u4F9B\u8005\uFF09\u306E\u81D3\u5668\u304C\u3001\u514D\u75AB\u5FDC\u7B54\u306B\u3088\u3063\u3066\u30EC\u30B7\u30D4\u30A8\u30F3\u30C8\u306E\u81D3\u5668\u3092\u653B\u6483\u3059\u308B\u3053\u3068\u306B\u3088\u3063\u3066\u8D77\u3053\u308B\u75C7\u72B6\u306E\u7DCF\u79F0\u3067\u3042\u308B\u3002 \u6DF7\u540C\u3055\u308C\u308B\u3053\u3068\u304C\u3042\u308B\u75C5\u614B\u3068\u3057\u3066\u3001\u3044\u308F\u3086\u308B\u62D2\u7D76\u53CD\u5FDC\u304C\u3042\u308B\u3002\u62D2\u7D76\u53CD\u5FDC\u306F\u30EC\u30B7\u30D4\u30A8\u30F3\u30C8\u306E\u514D\u75AB\u5FDC\u7B54\u306B\u3088\u3063\u3066\u30C9\u30CA\u30FC\u306E\u79FB\u690D\u7247\u304C\u653B\u6483\u3055\u308C\u308B\u3053\u3068\u306B\u3088\u308B\u5408\u4F75\u75C7\u306E\u7DCF\u79F0\u3067\u3042\u308A\u3001GVHD\u3068\u306F\u3001\u653B\u6483\u3059\u308B\u5074\u3068\u653B\u6483\u3055\u308C\u308B\u5074\u304C\u53CD\u5BFE\u3067\u3042\u308B\u3002 GVHD\u306F\u69D8\u3005\u306A\u4ED6\u5BB6\u81D3\u5668\u79FB\u690D\u306E\u5F8C\u306B\u767A\u751F\u3059\u308B\u304C\u3001\u7279\u306B\u514D\u75AB\u7D44\u7E54\u3092\u76F4\u63A5\u79FB\u690D\u3059\u308B\u3001\u9020\u8840\u5E79\u7D30\u80DE\u79FB\u690D\uFF08\u9AA8\u9AC4\u79FB\u690D\uFF09\u5F8C\u3084\u8F38\u8840\u5F8C\u306E\u3082\u306E\u304C\u77E5\u3089\u308C\u3066\u3044\u308B\uFF08GVHD\u306E\u5206\u985E\u3068\u8A3A\u65AD\uFF09\u3002"@ja . . . "\uC774\uC2DD\uD3B8\uB300\uC219\uC8FC\uBCD1(Graft-versus-host disease, GVHD)\uC740 \uBA74\uC5ED\uB825 \uC800\uD558 \uB4F1\uC758 \uC774\uC720\uB85C \uC9C4\uD589\uD55C \uC218\uD608 \uB4F1\uC758 \uCE58\uB8CC\uD589\uC704\uB97C \uD1B5\uD558\uC5EC \uC219\uC8FC \uB0B4\uB85C \uC720\uC785\uB41C \uD0C0\uC778\uC758 \uAC00 \uC219\uC8FC\uC758 \uBA74\uC5ED\uCCB4\uACC4\uC5D0 \uC758\uD558\uC5EC \uC0AC\uBA78\uB418\uC9C0 \uC54A\uACE0, \uC219\uC8FC\uC758 \uCCB4\uB0B4\uC5D0\uC11C \uC99D\uC2DD\uD558\uC5EC \uC219\uC8FC\uB97C \uACF5\uACA9\uD558\uB294 \uBCD1\uC73C\uB85C, \uC99D\uC0C1\uC758 \uC815\uB3C4\uC5D0 \uB530\uB77C \uC2EC\uD55C\uACBD\uC6B0 \uC0AC\uB9DD\uC5D0 \uC774\uB974\uAE30\uB3C4 \uD55C\uB2E4"@ko . "Graft versus host disease, GVHD, \u00E4r en allvarlig komplikation som ofta f\u00F6ljer en transplantation och i synnerhet benm\u00E4rgstransplantationer. Namnet kommer sig av att det transplanterade organet attackerar v\u00E4rden. Sjukdomen yttrar sig i feber, anorexi, diarr\u00E9, eksemlika utslag, leversvikt och buksm\u00E4rtor. Tillst\u00E5ndet orsakas av att immunceller i det transplanterade organet (t.ex. benm\u00E4rg) angriper mottagarens egen v\u00E4vnad och skadar den."@sv . . "La malaltia de l'empelt contra l'hoste (MECH) \u00E9s una s\u00EDndrome, caracteritzada per la inflamaci\u00F3 en diferents \u00F2rgans, at\u00E8s que els leuc\u00F2cits del sistema immunitari del donant que queden dins del teixit donat (l'empelt) reconeixen el receptor (l'hoste) com a estrany. Aix\u00ED, aquests leuc\u00F2cits ataquen les c\u00E8l\u00B7lules del cos del receptor, el que condueix a la malaltia. No s'ha de confondre amb un rebuig de trasplantament, que es produeix quan el sistema immunitari del receptor del trasplantament rebutja el teixit trasplantat. El principi subjacent (al\u00B7loimmunitat) \u00E9s el mateix, per\u00F2 els detalls i el curs poden diferir."@ca . . "Malaltia de l'empelt contra l'hoste"@ca . . . "Graft-versus-hostreactie"@nl . . . . . . . "A doen\u00E7a do enxerto contra hospedeiro, tamb\u00E9m conhecida como DECH ou GVHD (do ingl\u00EAs graft-versus-host disease), \u00E9 uma complica\u00E7\u00E3o comum do transplante de medula \u00F3ssea alog\u00EAnico no qual c\u00E9lulas imunes funcionais da medula \u00F3ssea transplantada, atrav\u00E9s de um fisiopatologia complexa que envolve o reconhecimento de ant\u00EDgenos e a\u00E7\u00E3o de linf\u00F3citos T, atacam c\u00E9lulas e tecidos do organismo receptor. Pode ser classificada em aguda ou cr\u00F4nica. A aguda caracteriza-se pela morte celular epitelial na pele, no tracto intestinal e no f\u00EDgado. Pode tornar-se fatal."@pt . . . . . . "Graft-versus-host disease (GvHD) is a syndrome, characterized by inflammation in different organs. GvHD is commonly associated with bone marrow transplants and stem cell transplants. White blood cells of the donor's immune system which remain within the donated tissue (the graft) recognize the recipient (the host) as foreign (non-self). The white blood cells present within the transplanted tissue then attack the recipient's body's cells, which leads to GvHD. This should not be confused with a transplant rejection, which occurs when the immune system of the transplant recipient rejects the transplanted tissue; GvHD occurs when the donor's immune system's white blood cells reject the recipient. The underlying principle (alloimmunity) is the same, but the details and course may differ. GvHD can also occur after a blood transfusion if the blood products used have not been irradiated or treated with an approved pathogen reduction system."@en . . . . . . "med"@en . . . "med"@en . "\uC774\uC2DD\uD3B8\uB300\uC219\uC8FC\uBCD1"@ko . . "Choroba przeszczep przeciw gospodarzowi, GVHD (od ang. graft-versus-host disease) \u2013 niepo\u017C\u0105dana reakcja fizjologiczna zachodz\u0105ca w organizmie biorcy przeszczepu pod wp\u0142ywem wprowadzonych obcych antygenowo limfocyt\u00F3w. Odpowiednik GVHD, w kt\u00F3rej kom\u00F3rki dawcy atakuj\u0105 antygeny obecne na powierzchni kom\u00F3rek nowotworowych wykorzystywany jest w terapii bia\u0142aczek (tak zwana reakcja )."@pl . . . . . "\u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u0636\u062F \u0627\u0644\u062B\u0648\u064A"@ar . . "Choroba przeszczep przeciw gospodarzowi, GVHD (od ang. graft-versus-host disease) \u2013 niepo\u017C\u0105dana reakcja fizjologiczna zachodz\u0105ca w organizmie biorcy przeszczepu pod wp\u0142ywem wprowadzonych obcych antygenowo limfocyt\u00F3w. Limfocyty T przyj\u0119te od dawcy naciekaj\u0105 (obce dla nich) tkanki gospodarza i doprowadzaj\u0105 do ich niszczenia. Najcz\u0119\u015Bciej zajmowanymi narz\u0105dami s\u0105 sk\u00F3ra, uk\u0142ad pokarmowy i w\u0105troba. Ryzyko choroby przeszczep przeciw gospodarzowi zmniejsza usuni\u0119cie zawiesiny limfocyt\u00F3w z materia\u0142u przeszczepowego, ale \u2013 z drugiej strony \u2013 nieobecno\u015B\u0107 leukocyt\u00F3w w przeszczepie grozi jego odrzuceniem (w tym przypadku na zasadzie \u201Egospodarz przeciw przeszczepowi\u201D). Odpowiednik GVHD, w kt\u00F3rej kom\u00F3rki dawcy atakuj\u0105 antygeny obecne na powierzchni kom\u00F3rek nowotworowych wykorzystywany jest w terapii bia\u0142aczek (tak zwana reakcja ). Choroba przeszczep przeciw gospodarzowi ma ci\u0119\u017Cki przebieg i mo\u017Ce prowadzi\u0107 nawet do \u015Bmierci pacjenta. Chorob\u0119 t\u0119 okre\u015Bla si\u0119 jako ostr\u0105, gdy rozwija si\u0119 w ci\u0105gu 100 dni od przeszczepu, i jako przewlek\u0142\u0105, gdy pojawia si\u0119 po tym czasie."@pl . . . . . "\uC774\uC2DD\uD3B8\uB300\uC219\uC8FC\uBCD1(Graft-versus-host disease, GVHD)\uC740 \uBA74\uC5ED\uB825 \uC800\uD558 \uB4F1\uC758 \uC774\uC720\uB85C \uC9C4\uD589\uD55C \uC218\uD608 \uB4F1\uC758 \uCE58\uB8CC\uD589\uC704\uB97C \uD1B5\uD558\uC5EC \uC219\uC8FC \uB0B4\uB85C \uC720\uC785\uB41C \uD0C0\uC778\uC758 \uAC00 \uC219\uC8FC\uC758 \uBA74\uC5ED\uCCB4\uACC4\uC5D0 \uC758\uD558\uC5EC \uC0AC\uBA78\uB418\uC9C0 \uC54A\uACE0, \uC219\uC8FC\uC758 \uCCB4\uB0B4\uC5D0\uC11C \uC99D\uC2DD\uD558\uC5EC \uC219\uC8FC\uB97C \uACF5\uACA9\uD558\uB294 \uBCD1\uC73C\uB85C, \uC99D\uC0C1\uC758 \uC815\uB3C4\uC5D0 \uB530\uB77C \uC2EC\uD55C\uACBD\uC6B0 \uC0AC\uB9DD\uC5D0 \uC774\uB974\uAE30\uB3C4 \uD55C\uB2E4"@ko . . . . . . . . . . . . "Graft-versus-host disease"@en . . . . . . . . "36808"^^ . "A doen\u00E7a do enxerto contra hospedeiro, tamb\u00E9m conhecida como DECH ou GVHD (do ingl\u00EAs graft-versus-host disease), \u00E9 uma complica\u00E7\u00E3o comum do transplante de medula \u00F3ssea alog\u00EAnico no qual c\u00E9lulas imunes funcionais da medula \u00F3ssea transplantada, atrav\u00E9s de um fisiopatologia complexa que envolve o reconhecimento de ant\u00EDgenos e a\u00E7\u00E3o de linf\u00F3citos T, atacam c\u00E9lulas e tecidos do organismo receptor. Pode ser classificada em aguda ou cr\u00F4nica. A aguda caracteriza-se pela morte celular epitelial na pele, no tracto intestinal e no f\u00EDgado. Pode tornar-se fatal. A cr\u00F3nica tem como caracter\u00EDstica a fibrose e atrofia de um ou mais \u00F3rg\u00E3os alvo e tamb\u00E9m pode vir a tornar-se fatal. Ambas as GVHD s\u00E3o normalmente tratadas com terapia de imunossupress\u00E3o."@pt . . . . . "5388" . "La malaltia de l'empelt contra l'hoste (MECH) \u00E9s una s\u00EDndrome, caracteritzada per la inflamaci\u00F3 en diferents \u00F2rgans, at\u00E8s que els leuc\u00F2cits del sistema immunitari del donant que queden dins del teixit donat (l'empelt) reconeixen el receptor (l'hoste) com a estrany. Aix\u00ED, aquests leuc\u00F2cits ataquen les c\u00E8l\u00B7lules del cos del receptor, el que condueix a la malaltia. No s'ha de confondre amb un rebuig de trasplantament, que es produeix quan el sistema immunitari del receptor del trasplantament rebutja el teixit trasplantat. El principi subjacent (al\u00B7loimmunitat) \u00E9s el mateix, per\u00F2 els detalls i el curs poden diferir. Tamb\u00E9 s'associa amb trasplantaments de c\u00E8l\u00B7lules mare com els que es produeixen amb trasplantament de medul\u00B7la \u00F2ssia. La MECH tamb\u00E9 s'aplica a altres formes de teixits trasplantats, com ara trasplantaments d'\u00F2rgans s\u00F2lids. La MECH tamb\u00E9 es pot produir despr\u00E9s d'una transfusi\u00F3 de sang si els productes sanguinis utilitzats no han estat irradiats o tractats convenientment."@ca . . . . . . . "Enfermedad de injerto contra hu\u00E9sped"@es . "Graft-versus-host disease"@it . . . . "\u79FB\u690D\u7247\u5BFE\u5BBF\u4E3B\u75C5\uFF08\u3044\u3057\u3087\u304F\u3078\u3093\u305F\u3044\u3057\u3085\u304F\u3057\u3085\u3073\u3087\u3046\u3001graft versus host disease; GVHD\uFF09\u3068\u306F\u81D3\u5668\u79FB\u690D\u306B\u4F34\u3046\u5408\u4F75\u75C7\u306E\u3072\u3068\u3064\u3002 \u79FB\u690D\u7247\uFF08\u30B0\u30E9\u30D5\u30C8\uFF09\u306B\u3068\u3063\u3066\u3001\u30EC\u30B7\u30D4\u30A8\u30F3\u30C8\uFF08\u81D3\u5668\u53D7\u7D66\u8005\uFF09\u306E\u4F53\u306F\u7570\u7269\u3067\u3042\u308B\u3002GVHD\u3068\u306F\u30C9\u30CA\u30FC\uFF08\u81D3\u5668\u63D0\u4F9B\u8005\uFF09\u306E\u81D3\u5668\u304C\u3001\u514D\u75AB\u5FDC\u7B54\u306B\u3088\u3063\u3066\u30EC\u30B7\u30D4\u30A8\u30F3\u30C8\u306E\u81D3\u5668\u3092\u653B\u6483\u3059\u308B\u3053\u3068\u306B\u3088\u3063\u3066\u8D77\u3053\u308B\u75C7\u72B6\u306E\u7DCF\u79F0\u3067\u3042\u308B\u3002 \u6DF7\u540C\u3055\u308C\u308B\u3053\u3068\u304C\u3042\u308B\u75C5\u614B\u3068\u3057\u3066\u3001\u3044\u308F\u3086\u308B\u62D2\u7D76\u53CD\u5FDC\u304C\u3042\u308B\u3002\u62D2\u7D76\u53CD\u5FDC\u306F\u30EC\u30B7\u30D4\u30A8\u30F3\u30C8\u306E\u514D\u75AB\u5FDC\u7B54\u306B\u3088\u3063\u3066\u30C9\u30CA\u30FC\u306E\u79FB\u690D\u7247\u304C\u653B\u6483\u3055\u308C\u308B\u3053\u3068\u306B\u3088\u308B\u5408\u4F75\u75C7\u306E\u7DCF\u79F0\u3067\u3042\u308A\u3001GVHD\u3068\u306F\u3001\u653B\u6483\u3059\u308B\u5074\u3068\u653B\u6483\u3055\u308C\u308B\u5074\u304C\u53CD\u5BFE\u3067\u3042\u308B\u3002 GVHD\u306F\u69D8\u3005\u306A\u4ED6\u5BB6\u81D3\u5668\u79FB\u690D\u306E\u5F8C\u306B\u767A\u751F\u3059\u308B\u304C\u3001\u7279\u306B\u514D\u75AB\u7D44\u7E54\u3092\u76F4\u63A5\u79FB\u690D\u3059\u308B\u3001\u9020\u8840\u5E79\u7D30\u80DE\u79FB\u690D\uFF08\u9AA8\u9AC4\u79FB\u690D\uFF09\u5F8C\u3084\u8F38\u8840\u5F8C\u306E\u3082\u306E\u304C\u77E5\u3089\u308C\u3066\u3044\u308B\uFF08GVHD\u306E\u5206\u985E\u3068\u8A3A\u65AD\uFF09\u3002"@ja . . . . "Graft versus host (letterlijk: tegen gastheer) is een verzamelnaam voor bepaalde complicaties van orgaantransplantaties. Vooral bij beenmergtransplantaties kan het donorweefsel (de graft) een afweerreactie vertonen tegen het weefsel van de ontvanger (de host). De afweercellen van het transplantaat vallen dus het weefsel van de gastheer aan, wat precies tegengesteld is aan de gebruikelijke afstoting: vrijwel altijd valt het weefsel van de ontvanger het donorweefsel aan."@nl . . . "\u79FB\u690D\u7269\u5C0D\u6297\u5BBF\u4E3B\u75BE\u75C5\uFF08Graft-versus-host disease\uFF09\u7C21\u7A31GvHD\uFF0C\u662F\u5728\u5F8C\u7522\u751F\u7684\u4F75\u767C\u75C7\u3002GvHD\u4E00\u822C\u548C\u9AA8\u9AD3\u79FB\u690D\u6709\u95DC\uFF0C\u4F46\u6B64\u6982\u5FF5\u4E5F\u53EF\u4EE5\u7528\u5728\u5176\u4ED6\u7D44\u7E54\u7684\u7684\u79FB\u690D\u4E0A\u3002GvHD\u662F\u79FB\u690D\u7269\u4E2D\u7684\u514D\u75AB\u7D30\u80DE\uFF08\u767D\u8840\u7403\uFF09\u5C07\u5BBF\u4E3B\u8996\u70BA\u7570\u7269\uFF0C\u56E0\u6B64\u653B\u64CA\u5BBF\u4E3B\u7D30\u80DE\u7684\u884C\u70BA\u3002\u82E5\u8F38\u8840\u7684\u8840\u6DB2\u88FD\u54C1\u672A\u7D93\u9069\u7576\u8655\u7406\uFF0C\u8F38\u8840\u5F8C\u4E5F\u53EF\u80FD\u51FA\u73FEGvHD\u7684\u60C5\u5F62\u3002 \u79FB\u690D\u7269\u5C0D\u6297\u5BBF\u4E3B\u75BE\u75C5\u548C\u79FB\u690D\u6392\u65A5\u4E0D\u540C\uFF0C\u79FB\u690D\u6392\u65A5\u662F\u5BBF\u4E3B\u6392\u65A5\u79FB\u690D\u7269\uFF0C\u800C\u79FB\u690D\u7269\u5C0D\u6297\u5BBF\u4E3B\u75BE\u75C5\u662F\u79FB\u690D\u7269\u6392\u65A5\u5BBF\u4E3B\uFF0C\u5169\u8005\u7684\u57FA\u672C\u539F\u7406\u90FD\u662F\uFF0C\u4E0D\u904E\u5176\u7D30\u7BC0\u53EF\u80FD\u6703\u6709\u4E9B\u4E0D\u540C\u3002"@zh . . . . . . . . . . . . . . . "001309" . . "Reakce \u0161t\u011Bpu proti hostiteli ozna\u010Dovan\u00E1 jako GvHD (anglicky graft versus host disease) je hlavn\u00ED zdravotn\u00ED komplikace po p\u0159ijet\u00ED transplant\u00E1tu kmenov\u00FDch bun\u011Bk od geneticky odli\u0161n\u00E9 osoby. GvHD spo\u010D\u00EDv\u00E1 v reakci T-bun\u011Bk p\u0159\u00EDtomn\u00FDch ve \u0161t\u011Bpu proti bu\u0148k\u00E1m p\u0159\u00EDjemce. T-bu\u0148ky rozezn\u00E1vaj\u00ED tk\u00E1\u0148ov\u00E9 antigeny p\u0159\u00EDjemce jako cizorod\u00E9 a reaguj\u00ED proti nim. N\u011Bkte\u0159\u00ED lid\u00E9 trp\u00ED po transplantaci m\u00EDrnou formu tohoto onemocn\u011Bn\u00ED, kter\u00E9 netrv\u00E1 dlouho. Na druhou stranu n\u011Bkte\u0159\u00ED mohou trp\u011Bt z\u00E1va\u017Enou formou, kter\u00E1 m\u016F\u017Ee b\u00FDt i smrteln\u00E1. GvHD se m\u016F\u017Ee vyskytnout i po krevn\u00ED transf\u00FAzi poskytnut\u00E9 imunodeficientn\u00EDmu \u010Dlov\u011Bku, pokud krevn\u00ED elementy nebyly p\u0159edem oz\u00E1\u0159eny."@cs . . . . "Is aimhr\u00E9idh neamhchoitianta \u00E9 An Galar N\u00F3d\u00FA in \u00E9adan \u00D3staigh , a bh\u00EDonn bainteach le fuilaistri\u00FA (GN-OBF), ina dtugann 'T limfic\u00EDt\u00ED' an deont\u00F3ra imoibri\u00FA imdh\u00EDoneola\u00EDoch i gcoinne f\u00EDoch\u00E1in limfeach an fhaighteora. De ghn\u00E1th, aithn\u00EDonn an faighteoir T limfic\u00EDt\u00ED an deont\u00F3ra mar earra\u00ED coimhth\u00EDocha, agus, d\u00E1 bhr\u00ED sin, scriosann c\u00F3ras imdh\u00EDonachta an fhaighteora iad."@ga . . "Reakce \u0161t\u011Bpu proti hostiteli ozna\u010Dovan\u00E1 jako GvHD (anglicky graft versus host disease) je hlavn\u00ED zdravotn\u00ED komplikace po p\u0159ijet\u00ED transplant\u00E1tu kmenov\u00FDch bun\u011Bk od geneticky odli\u0161n\u00E9 osoby. GvHD spo\u010D\u00EDv\u00E1 v reakci T-bun\u011Bk p\u0159\u00EDtomn\u00FDch ve \u0161t\u011Bpu proti bu\u0148k\u00E1m p\u0159\u00EDjemce. T-bu\u0148ky rozezn\u00E1vaj\u00ED tk\u00E1\u0148ov\u00E9 antigeny p\u0159\u00EDjemce jako cizorod\u00E9 a reaguj\u00ED proti nim."@cs . . . "Mouse colon impacted by acute graft-versus-host disease."@en . . . "926"^^ . "Graft versus host (letterlijk: tegen gastheer) is een verzamelnaam voor bepaalde complicaties van orgaantransplantaties. Vooral bij beenmergtransplantaties kan het donorweefsel (de graft) een afweerreactie vertonen tegen het weefsel van de ontvanger (de host). De afweercellen van het transplantaat vallen dus het weefsel van de gastheer aan, wat precies tegengesteld is aan de gebruikelijke afstoting: vrijwel altijd valt het weefsel van de ontvanger het donorweefsel aan. Graft-versus-hostreacties kunnen overal in het lichaam optreden, maar vooral in de huid, de darmen en de longen. Om graft-versus-host te onderdrukken kunnen afweeronderdrukkende middelen worden ingezet - met soms moeilijk te behandelen infecties tot gevolg."@nl . . . "T86.0" . . . "575888"^^ . "T86.0"@en . . . . . "\u064A\u0634\u0643\u0644 \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u0636\u062F \u0627\u0644\u062B\u064E\u0648\u064A\u060C \u0627\u0644\u0630\u064A \u064A\u0633\u0645\u0649 \u0623\u064A\u0636\u064B\u0627 \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u062D\u064A\u0627\u0644 \u0627\u0644\u062B\u064E\u0648\u064A \u0623\u0648 \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u0636\u062F \u0627\u0644\u0645\u064F\u0636\u064A\u0641\u060C \u0645\u062A\u0644\u0627\u0632\u0645\u0629 \u062A\u062A\u0645\u064A\u0632 \u0628\u062D\u062F\u0648\u062B \u0627\u0644\u062A\u0647\u0627\u0628 \u0641\u064A \u0623\u0639\u0636\u0627\u0621 \u0645\u062E\u062A\u0644\u0641\u0629. \u064A\u062D\u062F\u062B \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u0636\u062F \u0627\u0644\u062B\u0648\u064A \u0639\u0627\u062F\u0629 \u0628\u0639\u062F \u0632\u0631\u0627\u0639\u0629 \u0646\u062E\u0627\u0639 \u0627\u0644\u0639\u0638\u0645 \u0623\u0648 \u0632\u0631\u0627\u0639\u0629 \u0627\u0644\u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u062C\u0630\u0639\u064A\u0629. \u062A\u062A\u0639\u0631\u0641 \u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u062F\u0645 \u0627\u0644\u0628\u064A\u0636\u0627\u0621 \u0627\u0644\u0642\u0627\u062F\u0645\u0629 \u0645\u0646 \u0627\u0644\u062C\u0647\u0627\u0632 \u0627\u0644\u0645\u0646\u0627\u0639\u064A \u0644\u0644\u0645\u062A\u0628\u0631\u0650\u0639 \u0648\u0627\u0644\u062A\u064A \u062A\u0628\u0642\u0649 \u062F\u0627\u062E\u0644 \u0627\u0644\u0623\u0646\u0633\u062C\u0629 \u0627\u0644\u0645\u062A\u0628\u0631\u064E\u0639 \u0628\u0647\u0627 (\u0627\u0644\u0637\u0639\u0645) \u0639\u0644\u0649 \u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u062B\u0648\u064A (\u0627\u0644\u0645\u0636\u064A\u0641 \u0623\u0648 \u0627\u0644\u0645\u062A\u0644\u0642\u064A) \u0639\u0644\u0649 \u0623\u0646\u0647\u0627 \u062E\u0644\u0627\u064A\u0627 \u063A\u0631\u064A\u0628\u0629 (\u063A\u064A\u0631 \u0630\u0627\u062A\u064A\u0629). \u0648\u062A\u0647\u0627\u062C\u0645 \u0647\u0630\u0647 \u0627\u0644\u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u0628\u064A\u0636\u0627\u0621 \u062E\u0644\u0627\u064A\u0627 \u062C\u0633\u0645 \u0627\u0644\u0645\u062A\u0644\u0642\u064A\u060C \u0645\u0627 \u064A\u0624\u062F\u064A \u0625\u0644\u0649 \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u0636\u062F \u0627\u0644\u062B\u0648\u064A. \u064A\u062C\u0628 \u0627\u0644\u062A\u0645\u064A\u064A\u0632 \u0628\u064A\u0646 \u0647\u0630\u0647 \u0627\u0644\u062D\u0627\u0644\u0629 \u0648\u062D\u0627\u0644\u0629 \u0631\u0641\u0636 \u0627\u0644\u0637\u0639\u0645\u060C \u0627\u0644\u062A\u064A \u062A\u062D\u062F\u062B \u0639\u0646\u062F\u0645\u0627 \u064A\u0631\u0641\u0636 \u0627\u0644\u062C\u0647\u0627\u0632 \u0627\u0644\u0645\u0646\u0627\u0639\u064A \u0644\u0644\u0645\u062A\u0644\u0642\u064A \u0627\u0644\u0637\u0639\u0645 \u0627\u0644\u0645\u0632\u0631\u0648\u0639\u061B \u064A\u062D\u062F\u062B \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u0636\u062F \u0627\u0644\u062B\u0648\u064A \u0639\u0646\u062F\u0645\u0627 \u062A\u0631\u0641\u0636 \u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u062F\u0645 \u0627\u0644\u0628\u064A\u0636\u0627\u0621 \u0641\u064A \u0627\u0644\u062C\u0647\u0627\u0632 \u0627\u0644\u0645\u0646\u0627\u0639\u064A \u0644\u0644\u0645\u062A\u0628\u0631\u0650\u0639 \u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u0645\u062A\u0644\u0642\u064A. \u0623\u0635\u0644 \u0647\u0627\u062A\u064A\u0646 \u0627\u0644\u062D\u0627\u0644\u062A\u064A\u0646 \u0648\u0627\u062D\u062F (\u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0627\u0644\u062E\u064A\u0641\u064A\u0629)\u060C \u0648\u0644\u0643\u0646 \u0627\u0644\u062A\u0641\u0627\u0635\u064A\u0644 \u0648\u0627\u0644\u0645\u0633\u0627\u0631 \u0645\u062E\u062A\u0644\u0641\u0627\u0646. \u064A\u0645\u0643\u0646 \u0623\u0646 \u064A\u062D\u062F\u062B \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u0636\u062F \u0627\u0644\u062B\u0648\u064A \u0623\u064A\u0636\u064B\u0627 \u0628\u0639\u062F \u0646\u0642\u0644 \u0627\u0644\u062F\u0645 \u0625\u0630\u0627 \u0643\u0627\u0646\u062A \u0645\u0646\u062A\u062C\u0627\u062A \u0627\u0644\u062F\u0645 \u0627\u0644\u0645\u0646\u0642\u0648\u0644\u0629 \u063A\u064A\u0631 \u0645\u0634\u0639\u064E\u0639\u0629 \u0623\u0648 \u0645\u0639\u0627\u0644\u062C\u0629 \u0628\u0646\u0638\u0627\u0645 \u0645\u0639\u062A\u0645\u062F \u0644\u0644\u062D\u062F \u0645\u0646 \u0627\u0644\u0639\u0648\u0627\u0645\u0644 \u0627\u0644\u0645\u064F\u0645\u0652\u0631\u0636\u0629."@ar . . . . . . . . . . "An Galar N\u00F3d\u00FA in \u00E9adan \u00D3staigh"@ga . . . . . . . . "\u064A\u0634\u0643\u0644 \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u0636\u062F \u0627\u0644\u062B\u064E\u0648\u064A\u060C \u0627\u0644\u0630\u064A \u064A\u0633\u0645\u0649 \u0623\u064A\u0636\u064B\u0627 \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u062D\u064A\u0627\u0644 \u0627\u0644\u062B\u064E\u0648\u064A \u0623\u0648 \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u0636\u062F \u0627\u0644\u0645\u064F\u0636\u064A\u0641\u060C \u0645\u062A\u0644\u0627\u0632\u0645\u0629 \u062A\u062A\u0645\u064A\u0632 \u0628\u062D\u062F\u0648\u062B \u0627\u0644\u062A\u0647\u0627\u0628 \u0641\u064A \u0623\u0639\u0636\u0627\u0621 \u0645\u062E\u062A\u0644\u0641\u0629. \u064A\u062D\u062F\u062B \u0645\u0631\u0636 \u0627\u0644\u0637\u0639\u0645 \u0636\u062F \u0627\u0644\u062B\u0648\u064A \u0639\u0627\u062F\u0629 \u0628\u0639\u062F \u0632\u0631\u0627\u0639\u0629 \u0646\u062E\u0627\u0639 \u0627\u0644\u0639\u0638\u0645 \u0623\u0648 \u0632\u0631\u0627\u0639\u0629 \u0627\u0644\u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u062C\u0630\u0639\u064A\u0629."@ar . "279.5"^^ . . "Reakce \u0161t\u011Bpu proti hostiteli"@cs . . . "Graft-versus-host disease"@en . . . . "\u79FB\u690D\u7269\u5C0D\u6297\u5BBF\u4E3B\u75BE\u75C5"@zh . . . "La enfermedad de injerto contra hu\u00E9sped (EICH, o GVHD por la siglas en ingl\u00E9s de Graft-Versus-Host-Disease) es una complicaci\u00F3n m\u00E9dica com\u00FAn en determinados alotrasplantes de tejidos. Se asocia principalmente al trasplante de c\u00E9lulas pluripotenciales hematopoy\u00E9ticas, com\u00FAnmente denominado trasplante de m\u00E9dula \u00F3sea. En \u00FAltima instancia esta complicaci\u00F3n es debida a que las c\u00E9lulas inmunes presentes en el tejido trasplantado reconocen al receptor del trasplante (el hospedador) como \"extra\u00F1o\". Las c\u00E9lulas inmunes trasplantadas una vez activadas atacan a las c\u00E9lulas del receptor causando la enfermedad. En algunas ocasiones puede presentarse la enfermedad de injerto contra hu\u00E9sped despu\u00E9s de una transfusi\u00F3n sangu\u00EDnea."@es . . . . . . . . . . . "La malattia del trapianto contro l'ospite (inglese graft-versus-host disease, da cui la sigla GvHD) \u00E8 una complicanza medica che segue la ricezione del tessuto trapiantato da una persona geneticamente diversa. La GvHD \u00E8 comunemente associata al trapianto di cellule staminali (trapianto di midollo osseo), ma il termine si applica anche ad altre forme di innesto tissutale. Le cellule immunitarie (globuli bianchi) nel tessuto donato (l'innesto) riconoscono il destinatario (l'host) come estraneo (nonself). Le cellule immunitarie trapiantate attaccano quindi le cellule del corpo dell'ospite. La GvHD pu\u00F2 verificarsi anche dopo una trasfusione di sangue se i prodotti ematici utilizzati non sono stati irradiati o trattati con un sistema di riduzione degli agenti patogeni approvati. Mentre il rigetto del trapianto avviene quando l'ospite rifiuta l'innesto, la GvHD si verifica quando l'innesto rifiuta l'host. Il principio sottostante (allo-immunit\u00E0) \u00E8 lo stesso, ma i dettagli e il decorso possono differire. Casi specifici riguardano il trapianto delle cellule staminali periferiche allogeniche e il trapianto di midollo osseo."@it . . . . . . "Graft versus host disease"@sv . . "Graft-versus-Host-Reaktion"@de . . "\u79FB\u690D\u7269\u5C0D\u6297\u5BBF\u4E3B\u75BE\u75C5\uFF08Graft-versus-host disease\uFF09\u7C21\u7A31GvHD\uFF0C\u662F\u5728\u5F8C\u7522\u751F\u7684\u4F75\u767C\u75C7\u3002GvHD\u4E00\u822C\u548C\u9AA8\u9AD3\u79FB\u690D\u6709\u95DC\uFF0C\u4F46\u6B64\u6982\u5FF5\u4E5F\u53EF\u4EE5\u7528\u5728\u5176\u4ED6\u7D44\u7E54\u7684\u7684\u79FB\u690D\u4E0A\u3002GvHD\u662F\u79FB\u690D\u7269\u4E2D\u7684\u514D\u75AB\u7D30\u80DE\uFF08\u767D\u8840\u7403\uFF09\u5C07\u5BBF\u4E3B\u8996\u70BA\u7570\u7269\uFF0C\u56E0\u6B64\u653B\u64CA\u5BBF\u4E3B\u7D30\u80DE\u7684\u884C\u70BA\u3002\u82E5\u8F38\u8840\u7684\u8840\u6DB2\u88FD\u54C1\u672A\u7D93\u9069\u7576\u8655\u7406\uFF0C\u8F38\u8840\u5F8C\u4E5F\u53EF\u80FD\u51FA\u73FEGvHD\u7684\u60C5\u5F62\u3002 \u79FB\u690D\u7269\u5C0D\u6297\u5BBF\u4E3B\u75BE\u75C5\u548C\u79FB\u690D\u6392\u65A5\u4E0D\u540C\uFF0C\u79FB\u690D\u6392\u65A5\u662F\u5BBF\u4E3B\u6392\u65A5\u79FB\u690D\u7269\uFF0C\u800C\u79FB\u690D\u7269\u5C0D\u6297\u5BBF\u4E3B\u75BE\u75C5\u662F\u79FB\u690D\u7269\u6392\u65A5\u5BBF\u4E3B\uFF0C\u5169\u8005\u7684\u57FA\u672C\u539F\u7406\u90FD\u662F\uFF0C\u4E0D\u904E\u5176\u7D30\u7BC0\u53EF\u80FD\u6703\u6709\u4E9B\u4E0D\u540C\u3002"@zh . "D006086" . . . "La malattia del trapianto contro l'ospite (inglese graft-versus-host disease, da cui la sigla GvHD) \u00E8 una complicanza medica che segue la ricezione del tessuto trapiantato da una persona geneticamente diversa. La GvHD \u00E8 comunemente associata al trapianto di cellule staminali (trapianto di midollo osseo), ma il termine si applica anche ad altre forme di innesto tissutale. Le cellule immunitarie (globuli bianchi) nel tessuto donato (l'innesto) riconoscono il destinatario (l'host) come estraneo (nonself). Le cellule immunitarie trapiantate attaccano quindi le cellule del corpo dell'ospite."@it . . . . . . . . . . . . "Graft-versus-host disease"@en . "Unter der Graft-versus-Host-Reaktion (GvHR; deutsch: Transplantat-gegen-Wirt-Reaktion; englisch: graft-versus-host disease (GvHD)) versteht man eine immunologische Reaktion, die in der Folge einer allogenen Knochenmark- oder Stammzelltransplantation auftreten kann. Bei der GvHR reagieren vor allem die im Transplantat enthaltenen T-Lymphozyten eines Spenders gegen den Empf\u00E4ngerorganismus. Am h\u00E4ufigsten \u00E4u\u00DFern sich Symptome der GvHR an der Haut, der Leber, am Darm und am Auge. Die GvHR wird dabei nach Auspr\u00E4gung und Anzahl der befallenen Organe in vier Schweregrade eingeteilt."@de . . "D006086"@en . . . "Unter der Graft-versus-Host-Reaktion (GvHR; deutsch: Transplantat-gegen-Wirt-Reaktion; englisch: graft-versus-host disease (GvHD)) versteht man eine immunologische Reaktion, die in der Folge einer allogenen Knochenmark- oder Stammzelltransplantation auftreten kann. Bei der GvHR reagieren vor allem die im Transplantat enthaltenen T-Lymphozyten eines Spenders gegen den Empf\u00E4ngerorganismus. Am h\u00E4ufigsten \u00E4u\u00DFern sich Symptome der GvHR an der Haut, der Leber, am Darm und am Auge. Die GvHR wird dabei nach Auspr\u00E4gung und Anzahl der befallenen Organe in vier Schweregrade eingeteilt."@de . . "1122754614"^^ . . . . "Is aimhr\u00E9idh neamhchoitianta \u00E9 An Galar N\u00F3d\u00FA in \u00E9adan \u00D3staigh , a bh\u00EDonn bainteach le fuilaistri\u00FA (GN-OBF), ina dtugann 'T limfic\u00EDt\u00ED' an deont\u00F3ra imoibri\u00FA imdh\u00EDoneola\u00EDoch i gcoinne f\u00EDoch\u00E1in limfeach an fhaighteora. De ghn\u00E1th, aithn\u00EDonn an faighteoir T limfic\u00EDt\u00ED an deont\u00F3ra mar earra\u00ED coimhth\u00EDocha, agus, d\u00E1 bhr\u00ED sin, scriosann c\u00F3ras imdh\u00EDonachta an fhaighteora iad. Mar sin f\u00E9in, i gc\u00E1sanna ina bhfuil sochtadh imdh\u00EDonachta ag an bhfaighteoir sochtadh imdh\u00EDonachta \u00F3 bhreith n\u00F3 faighte, urch\u00F3ideacht ), n\u00F3 nuair a bh\u00EDonn an deont\u00F3ir homaisigeach agus an faighteoir heitrisigeach d'aont\u00EDop\u00E1il den Antaigin Leocaic\u00EDt Dhaonna (mar a tharla\u00EDonn i roinnt fhuilaistrithe \u00F3 ghaolta den ch\u00E9ad ch\u00E9im), n\u00ED bh\u00EDonn c\u00F3ras imdh\u00EDonachta an fhaighteora in ann T limfic\u00EDt\u00ED an deont\u00F3ra a scrios. De thoradh ar seo, is f\u00E9idir leis an ngalar n\u00F3d\u00FA in \u00E9adan \u00F3staigh teacht ar an othar."@ga . . . . . . . "1309"^^ . "Graft versus host disease, GVHD, \u00E4r en allvarlig komplikation som ofta f\u00F6ljer en transplantation och i synnerhet benm\u00E4rgstransplantationer. Namnet kommer sig av att det transplanterade organet attackerar v\u00E4rden. Sjukdomen yttrar sig i feber, anorexi, diarr\u00E9, eksemlika utslag, leversvikt och buksm\u00E4rtor. Tillst\u00E5ndet orsakas av att immunceller i det transplanterade organet (t.ex. benm\u00E4rg) angriper mottagarens egen v\u00E4vnad och skadar den. S\u00E4rskilt ofta \u00E4r MHC-molekyler i mottagaren f\u00F6rem\u00E5l f\u00F6r angreppet, d\u00E4rf\u00F6r str\u00E4var man alltid efter att hitta mottagare och donator med s\u00E5 lika MHC-strukturer som m\u00F6jligt. I fallet med benm\u00E4rgstransplantation \u00E4r det absolut n\u00F6dv\u00E4ndigt att mottagare och donator har 100% identiska MHC."@sv . "926"@en . . . . "La enfermedad de injerto contra hu\u00E9sped (EICH, o GVHD por la siglas en ingl\u00E9s de Graft-Versus-Host-Disease) es una complicaci\u00F3n m\u00E9dica com\u00FAn en determinados alotrasplantes de tejidos. Se asocia principalmente al trasplante de c\u00E9lulas pluripotenciales hematopoy\u00E9ticas, com\u00FAnmente denominado trasplante de m\u00E9dula \u00F3sea. En \u00FAltima instancia esta complicaci\u00F3n es debida a que las c\u00E9lulas inmunes presentes en el tejido trasplantado reconocen al receptor del trasplante (el hospedador) como \"extra\u00F1o\". Las c\u00E9lulas inmunes trasplantadas una vez activadas atacan a las c\u00E9lulas del receptor causando la enfermedad. En algunas ocasiones puede presentarse la enfermedad de injerto contra hu\u00E9sped despu\u00E9s de una transfusi\u00F3n sangu\u00EDnea."@es . "\u79FB\u690D\u7247\u5BFE\u5BBF\u4E3B\u75C5"@ja . "5388"^^ . . "Choroba przeszczep przeciw gospodarzowi"@pl . . "279.50" .